Recent studies utilizing genome‐wide in vivo CRISPR screening have identified STAU2 as a crucial molecule in myeloid leukemia.[47] STAU2 knockout significantly inhibited the myeloid leukemia progression. The gene discussed is STAU2; the disease is myeloid leukemia.